(19)
(11) EP 1 259 546 A1

(12)

(43) Date of publication:
27.11.2002 Bulletin 2002/48

(21) Application number: 01905970.8

(22) Date of filing: 22.02.2001
(51) International Patent Classification (IPC)7C07K 14/715, C12Q 1/68
(86) International application number:
PCT/GB0100/755
(87) International publication number:
WO 0106/2796 (30.08.2001 Gazette 2001/35)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 22.02.2000 GB 0004183

(71) Applicant: SMITHKLINE BEECHAM PLC
Brentford,Middlesex TW8 9GS (GB)

(72) Inventors:
  • VALDES, Ana Maria,GlaxoSmithKline
    Harlow,Essex CM19 5AW (GB)
  • GROOT, Pieter, Hendrik, Evert,GlaxoSmithKline
    Harlow, Essex CM19 5AW (GB)
  • SPURR, Nigel, Kay
    Research Triangle Park,NC 27709 (US)

(74) Representative: Giddings, Peter John, Dr. 
GlaxoSmithKlineCorporate Intellectual Property (CN9.25.1)980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) CCR2-64I, POLYMORPHIC VARIANT OF THE HUMAN CCR2 RECEPTOR AND ITS USE IN THE DIAGNOSTIC AND TREATMENT OF ATHEROSCLEROSIS